Sunday, February 9, 2025
My favorite among the major pharmaceutical companies remains AstraZeneca (AZN). One of the main reasons is that the company specializes in one of the areas where personalized medicine is making the greatest strides: oncology, in which AstraZeneca is the recognized leader. AstraZeneca already has three blockbuster oncology drugs. Here’s what Morningstar said about these drugs […]
The largest player in mortgage lending announced it has pulled its plans to dominate the home loan industry. That change is positive news for one of my favorite mortgage finance companies and its shares. Let’s take a look at the news, and how to get in… This excerpt comes from an email from Seeking Alpha: […]
Earnings season is upon us, so there tends to be a lot of big options trades as strategists position themselves for the results. 2022 was a rough year for many tech stocks, including Alphabet Class C Shares (GOOG). However, what appears to be a large bullish call spread traded recently in GOOG options. The call […]
With stock prices turning positive over the last few weeks, it’s easy to lose sight of the fact that share prices for many sectors remain down a lot from their early-2022 levels. I was surprised when I recently reviewed some 30-day stock price changes. There remain tremendous, high-yield values in which to invest. Here’s three […]
Scientists began warning of a potential “twindemic” – a simultaneous surge in both Covid-19 and flu cases – in the autumn. Add in the respiratory syncytial virus (RSV) into the mix and you have the United States in the throes of a viral “tripledemic”. In early December, the U.S. Centers for Disease Control and Prevention […]
Beleaguered retailer Bed Bath & Beyond (BBBY) was once a favorite among meme stock traders. But just last week, the company expressed doubt that it will be able to continue operating without filing bankruptcy. The stock price dropped 25% on the news, falling under $2 a share. Most options action on the day appeared to […]
Bear markets tend to move in 3 stages. I believe we just entered stage 2 (yes, only stage 2 at this point!). There’s one US economic chart I’m looking at today that verifies what I’m telling you. Every Thursday, I share weekly videos like this for free. This video is under 3 minutes so it’s […]
It’s safe to say that most market participants know about Warren Buffett. It would be hard not to since, in addition to a fantastic track record, he and his partner in crime, Charlie Munger, also get a lot of attention in the media. After all, a billionaire curmudgeon whose uncommon intellect and blunt manner make […]
Last year, the energy sector was the only market sector to post a positive return—and it did a heck of a job! The Energy Select Sector SPDR (XLE) gained 60% last year. One-year gains like that may make you cautious about committing to energy this year, but I believe your portfolio should continue to hold […]
Before the coronavirus pandemic, most of us had never heard of mRNA vaccines, which is not surprising. Although scientists had been experimenting with the technology for literally decades (reminiscent of fusion), the technology had never progressed beyond the laboratory and into widespread medical use. But now, many of us have been vaccinated against COVID-19 with […]
